NOS2 and lung carcinoma: Several microRNAs are implicated in inflammation-associated carcinogenesis, and genetic ablation of NOS2 in a genetically engineered mouse model of KRAS-induced lung cancer reduced the expression of oncomir-21 [20, 21].